Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Affective and psychotic disorders in multiple sclerosis].
Lower motor neuron involvement in longitudinally extensive transverse myelitis with and without aquaporin-4 antibodies.
Factors associated with poor sleep quality in patients with multiple sclerosis differ by disease duration.
Tetrahydrocannabinol
Imipramine and fluoxetine inhibit LPS-induced activation and affect morphology of microglial cells in the rat glial culture.
LEBER'S DISEASE WITH SYMPTOMS RESEMBLING DISSEMINATED SCLEROSIS.
Defining the new end point for multiple sclerosis treatment.
Immunomodulatory activity of interferon-beta.
Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy.
Significant clinical worsening after natalizumab withdrawal: Predictive factors.
NFAT1 deficit and NFAT2 deficit attenuate EAE via different mechanisms.
Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin α-4-transduced outside-in signalling.
Surgical Outcomes of Trigeminal Neuralgia in Patients with Multiple Sclerosis.
Electrophysiological features of POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
[Ophthalmological Findings in Paediatric and Adolescent Multiple Sclerosis.]
Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis.
[Neurodegenerative process in multiple sclerosis and a possible neuroprotective effect of Β-interferon 1a (avonex).]
'Hidden' factors influencing quality of life in patients with multiple sclerosis.
Primary Cutaneous Cryptococcus in a Patient With Multiple Sclerosis Treated With Fingolimod.
Fingolimod induces neurogenesis in adult mouse hippocampus and improves contextual fear memory.
Contemporary treatment options for relapsing-remitting multiple sclerosis.
The experimental autoimmune encephalomyelitis disease course is modulated by nicotine and other cigarette smoke components.
Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.
OPtimizing CNS drug development using molecular imaging.
Pelizaeus-Merzbacher disease-associated proteolipid protein 1 inhibits oligodendrocyte precursor cell differentiation via extracellular-signal regulated kinase signaling.

Pages